Hey ESPIN,I'm assuming no reply from Tim Boyd?He's prob too busy...

Hey ESPIN,

I'm assuming no reply from Tim Boyd?

He's prob too busy thinking about how he can help himself to more of our $$$.

Biosignal shareholders also approved a lucrative deal in March for current chairman and director Tim Boyd, who arranged the RGM acquisition, after Biosignal posted three years of operating losses.

He will receive a success fee of $150,000, as well as 200,000 share options and 200,000 shares to a nominee company.